1. Home
  2. TTD vs MEDP Comparison

TTD vs MEDP Comparison

Compare TTD & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Trade Desk Inc.

TTD

The Trade Desk Inc.

HOLD

Current Price

$17.95

Market Cap

8.1B

Sector

Technology

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$592.77

Market Cap

15.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTD
MEDP
Founded
2009
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
15.4B
IPO Year
2016
2016

Fundamental Metrics

Financial Performance
Metric
TTD
MEDP
Price
$17.95
$592.77
Analyst Decision
Buy
Hold
Analyst Count
34
12
Target Price
$46.22
$473.17
AVG Volume (30 Days)
12.8M
353.5K
Earning Date
05-07-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
15.38
20.98
EPS
0.08
8.53
Revenue
$2,896,284,000.00
N/A
Revenue This Year
$13.94
$13.19
Revenue Next Year
$12.61
$7.75
P/E Ratio
$216.13
$70.50
Revenue Growth
18.47
N/A
52 Week Low
$16.70
$373.00
52 Week High
$91.45
$677.90

Technical Indicators

Market Signals
Indicator
TTD
MEDP
Relative Strength Index (RSI) 46.17 71.47
Support Level $16.98 $577.01
Resistance Level $20.54 $622.32
Average True Range (ATR) 0.83 20.72
MACD -0.09 4.15
Stochastic Oscillator 41.07 50.47

Price Performance

Historical Comparison
TTD
MEDP

About TTD The Trade Desk Inc.

The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. The firm's platform is referred to as a DSP in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising, sometimes referred to as a "take rate".

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: